1. Home
  2. SNDL vs OBIO Comparison

SNDL vs OBIO Comparison

Compare SNDL & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SNDL Inc.

SNDL

SNDL Inc.

N/A

Current Price

$1.41

Market Cap

302.7M

Sector

Health Care

ML Signal

N/A

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$5.99

Market Cap

362.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNDL
OBIO
Founded
2006
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
302.7M
362.4M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SNDL
OBIO
Price
$1.41
$5.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.27
★ $12.43
AVG Volume (30 Days)
★ 1.3M
397.1K
Earning Date
10-27-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.13
EPS
★ N/A
N/A
Revenue
N/A
★ $33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$33.03
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1169.22
52 Week Low
$1.13
$3.46
52 Week High
$2.34
$6.50

Technical Indicators

Market Signals
Indicator
SNDL
OBIO
Relative Strength Index (RSI) 61.52 54.72
Support Level $1.34 $5.54
Resistance Level $1.47 $5.98
Average True Range (ATR) 0.06 0.39
MACD 0.02 0.00
Stochastic Oscillator 87.50 70.16

Price Performance

Historical Comparison
SNDL
OBIO

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: